All Comments by Peter Davies

  1. Post-Brexit U.K. Picks Belgian to Run Its Flagship Dementia Research Institute
  2. Inventory of Tau Modifications Hints at Undiscovered Functions
  3. Specific calpain inhibition by calpastatin prevents tauopathy and neurodegeneration and restores normal lifespan in tau P301L mice.
  4. Mechanistic basis of phenothiazine-driven inhibition of tau aggregation.
  5. Hyperdynamic microtubules, cognitive deficits, and pathology are improved in tau transgenic mice with low doses of the microtubule-stabilizing agent BMS-241027.
  6. NIH Director Announces $100M Prevention Trial of Genentech Antibody
  7. Genetic reduction of striatal-enriched tyrosine phosphatase (STEP) reverses cognitive and cellular deficits in an Alzheimer's disease mouse model.
  8. A Tribute to Robert Katzman
  9. Gain or Loss of Function—Time to Shake up Assumptions on γ-Secretase in Alzheimer Disease?
  10. Gain or Loss of Function—Time to Shake up Assumptions on γ-Secretase in Alzheimer Disease?
  11. We Are What We Consume? Foods, Drugs Affect Amyloid, AD
  12. Can Travel, Will Deposit: Aβ via the Perforant Pathway?
  13. Spinal Taps for Tau Tests
  14. Mutations of tau protein in frontotemporal dementia promote aggregation of paired helical filaments by enhancing local beta-structure.
  15. Bax protein expression is increased in Alzheimer's brain: correlations with DNA damage, Bcl-2 expression, and brain pathology.